| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Angelman Syndrome | 17 | 2025 | 67 | 2.700 |
Why?
|
| Chromosome Deletion | 25 | 2018 | 653 | 2.670 |
Why?
|
| Intellectual Disability | 37 | 2026 | 1089 | 2.550 |
Why?
|
| Abnormalities, Multiple | 29 | 2026 | 963 | 2.120 |
Why?
|
| Achondroplasia | 11 | 2026 | 24 | 2.080 |
Why?
|
| Neurodevelopmental Disorders | 15 | 2025 | 629 | 1.900 |
Why?
|
| DNA Copy Number Variations | 25 | 2025 | 1027 | 1.750 |
Why?
|
| Chromosome Aberrations | 20 | 2019 | 573 | 1.670 |
Why?
|
| Phenotype | 54 | 2026 | 4483 | 1.570 |
Why?
|
| Natriuretic Peptide, C-Type | 9 | 2026 | 15 | 1.390 |
Why?
|
| Mutation | 36 | 2026 | 6080 | 1.310 |
Why?
|
| Developmental Disabilities | 20 | 2026 | 781 | 1.090 |
Why?
|
| Exons | 12 | 2025 | 759 | 1.040 |
Why?
|
| Translocation, Genetic | 13 | 2016 | 344 | 1.030 |
Why?
|
| Mutation, Missense | 13 | 2026 | 918 | 1.030 |
Why?
|
| Microcephaly | 9 | 2026 | 347 | 1.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 17 | 2025 | 992 | 0.970 |
Why?
|
| Comparative Genomic Hybridization | 23 | 2016 | 566 | 0.960 |
Why?
|
| Child, Preschool | 86 | 2026 | 15048 | 0.960 |
Why?
|
| Gene Duplication | 9 | 2016 | 358 | 0.940 |
Why?
|
| In Situ Hybridization, Fluorescence | 33 | 2016 | 741 | 0.940 |
Why?
|
| Pedigree | 30 | 2026 | 1676 | 0.930 |
Why?
|
| Chromosome Disorders | 9 | 2018 | 316 | 0.910 |
Why?
|
| Bone Diseases, Developmental | 7 | 2019 | 64 | 0.900 |
Why?
|
| Craniofacial Abnormalities | 8 | 2019 | 251 | 0.830 |
Why?
|
| Chromosomes, Human, Pair 15 | 9 | 2016 | 143 | 0.820 |
Why?
|
| Haploinsufficiency | 11 | 2024 | 265 | 0.810 |
Why?
|
| Humans | 198 | 2026 | 130611 | 0.800 |
Why?
|
| Child | 92 | 2026 | 26262 | 0.800 |
Why?
|
| Female | 135 | 2026 | 70631 | 0.750 |
Why?
|
| Infant | 59 | 2026 | 13308 | 0.730 |
Why?
|
| Sequence Deletion | 15 | 2024 | 515 | 0.720 |
Why?
|
| Male | 125 | 2026 | 64659 | 0.710 |
Why?
|
| Ubiquitin-Protein Ligases | 7 | 2025 | 352 | 0.700 |
Why?
|
| Chromosomes, Human, Pair 17 | 8 | 2018 | 363 | 0.690 |
Why?
|
| Osteochondrodysplasias | 8 | 2019 | 68 | 0.690 |
Why?
|
| Ectodermal Dysplasia | 3 | 2020 | 62 | 0.680 |
Why?
|
| Trisomy | 5 | 2012 | 111 | 0.680 |
Why?
|
| Chromosomes, Human, Pair 16 | 8 | 2017 | 147 | 0.680 |
Why?
|
| Chromosomes, Human, Pair 1 | 6 | 2008 | 145 | 0.670 |
Why?
|
| Pigmentation Disorders | 4 | 2018 | 22 | 0.660 |
Why?
|
| Genetic Diseases, Inborn | 7 | 2021 | 468 | 0.660 |
Why?
|
| Transcription Factors | 10 | 2023 | 2403 | 0.650 |
Why?
|
| Prader-Willi Syndrome | 3 | 2021 | 62 | 0.630 |
Why?
|
| Chromosome Duplication | 5 | 2017 | 146 | 0.610 |
Why?
|
| Syndrome | 23 | 2024 | 1155 | 0.610 |
Why?
|
| Nucleic Acid Hybridization | 4 | 2009 | 295 | 0.560 |
Why?
|
| Autism Spectrum Disorder | 5 | 2023 | 450 | 0.560 |
Why?
|
| Genome, Human | 14 | 2025 | 1320 | 0.560 |
Why?
|
| Alleles | 14 | 2024 | 1673 | 0.540 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 2016 | 108 | 0.540 |
Why?
|
| Mosaicism | 9 | 2020 | 247 | 0.530 |
Why?
|
| Clubfoot | 2 | 2014 | 19 | 0.510 |
Why?
|
| Motor Activity | 1 | 2020 | 489 | 0.510 |
Why?
|
| Congenital Abnormalities | 5 | 2025 | 328 | 0.510 |
Why?
|
| Body Height | 6 | 2024 | 192 | 0.490 |
Why?
|
| Chromosomes, Human, Pair 8 | 3 | 2009 | 77 | 0.490 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2016 | 18 | 0.490 |
Why?
|
| Nerve Tissue Proteins | 3 | 2026 | 1075 | 0.480 |
Why?
|
| Exome | 16 | 2024 | 1061 | 0.480 |
Why?
|
| Genetic Predisposition to Disease | 15 | 2021 | 3422 | 0.480 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2016 | 53 | 0.480 |
Why?
|
| Betaine | 2 | 2019 | 19 | 0.470 |
Why?
|
| Adolescent | 49 | 2024 | 20893 | 0.470 |
Why?
|
| p120 GTPase Activating Protein | 1 | 2016 | 7 | 0.470 |
Why?
|
| Autistic Disorder | 9 | 2014 | 397 | 0.470 |
Why?
|
| DNA-Binding Proteins | 11 | 2024 | 1935 | 0.470 |
Why?
|
| Genetic Testing | 8 | 2024 | 1105 | 0.470 |
Why?
|
| Neurocutaneous Syndromes | 1 | 2016 | 17 | 0.460 |
Why?
|
| Frameshift Mutation | 1 | 2016 | 199 | 0.450 |
Why?
|
| Language Development Disorders | 6 | 2021 | 177 | 0.440 |
Why?
|
| Fibroblasts | 5 | 2024 | 849 | 0.440 |
Why?
|
| Folic Acid | 4 | 2019 | 269 | 0.430 |
Why?
|
| Craniosynostoses | 2 | 2017 | 146 | 0.430 |
Why?
|
| Gene Rearrangement | 4 | 2015 | 322 | 0.430 |
Why?
|
| Epilepsy | 6 | 2022 | 876 | 0.430 |
Why?
|
| Siblings | 3 | 2023 | 201 | 0.420 |
Why?
|
| Gene Deletion | 11 | 2024 | 766 | 0.400 |
Why?
|
| Genetic Linkage | 4 | 2010 | 461 | 0.390 |
Why?
|
| Base Sequence | 12 | 2016 | 2727 | 0.390 |
Why?
|
| Brain Diseases | 3 | 2022 | 298 | 0.390 |
Why?
|
| Proteins | 4 | 2018 | 1005 | 0.390 |
Why?
|
| Uniparental Disomy | 2 | 2012 | 42 | 0.380 |
Why?
|
| Hand Deformities, Congenital | 4 | 2026 | 96 | 0.370 |
Why?
|
| Chromosomes, Human, Pair 14 | 3 | 2012 | 94 | 0.350 |
Why?
|
| Karyotyping | 13 | 2012 | 308 | 0.350 |
Why?
|
| Infant, Newborn | 34 | 2020 | 8610 | 0.350 |
Why?
|
| Consanguinity | 1 | 2012 | 115 | 0.350 |
Why?
|
| Polymorphism, Single Nucleotide | 10 | 2025 | 2827 | 0.340 |
Why?
|
| Skin | 3 | 2021 | 544 | 0.340 |
Why?
|
| Noonan Syndrome | 2 | 2009 | 31 | 0.340 |
Why?
|
| Limb Deformities, Congenital | 4 | 2019 | 116 | 0.340 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 3 | 2024 | 401 | 0.330 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 2010 | 77 | 0.330 |
Why?
|
| Telomere | 4 | 2013 | 219 | 0.330 |
Why?
|
| Chromosomes, Human, Pair 12 | 2 | 2012 | 91 | 0.320 |
Why?
|
| X Chromosome | 3 | 2000 | 327 | 0.320 |
Why?
|
| Sequence Analysis, DNA | 10 | 2020 | 1688 | 0.320 |
Why?
|
| Double-Blind Method | 8 | 2026 | 1613 | 0.310 |
Why?
|
| Cytoskeletal Proteins | 5 | 2016 | 258 | 0.310 |
Why?
|
| Osteogenesis | 3 | 2020 | 182 | 0.310 |
Why?
|
| Repressor Proteins | 3 | 2025 | 759 | 0.310 |
Why?
|
| Chromosomes, Human, Pair 6 | 3 | 2018 | 137 | 0.310 |
Why?
|
| Musculoskeletal Abnormalities | 2 | 2021 | 67 | 0.310 |
Why?
|
| Genetic Association Studies | 9 | 2026 | 819 | 0.300 |
Why?
|
| Brain | 11 | 2024 | 3163 | 0.300 |
Why?
|
| Growth Disorders | 5 | 2021 | 181 | 0.300 |
Why?
|
| Microarray Analysis | 4 | 2019 | 222 | 0.290 |
Why?
|
| Adult | 36 | 2024 | 31146 | 0.290 |
Why?
|
| Behavior | 2 | 2010 | 70 | 0.280 |
Why?
|
| Mitochondria | 4 | 2026 | 782 | 0.280 |
Why?
|
| Heart Defects, Congenital | 10 | 2024 | 1880 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 2 | 4 | 2013 | 121 | 0.280 |
Why?
|
| Nuclear Proteins | 5 | 2020 | 1210 | 0.280 |
Why?
|
| Cleft Palate | 2 | 2024 | 221 | 0.280 |
Why?
|
| Mitochondrial Proteins | 4 | 2018 | 283 | 0.280 |
Why?
|
| Bone and Bones | 5 | 2021 | 308 | 0.270 |
Why?
|
| GTP Phosphohydrolases | 3 | 2018 | 155 | 0.270 |
Why?
|
| Seizures | 7 | 2023 | 889 | 0.270 |
Why?
|
| Rare Diseases | 4 | 2021 | 210 | 0.270 |
Why?
|
| Classical Lissencephalies and Subcortical Band Heterotopias | 2 | 2023 | 14 | 0.270 |
Why?
|
| Spasms, Infantile | 2 | 2022 | 165 | 0.260 |
Why?
|
| Homozygote | 6 | 2019 | 533 | 0.260 |
Why?
|
| Hedgehog Proteins | 2 | 2023 | 199 | 0.260 |
Why?
|
| Chromosome Breakage | 7 | 2011 | 154 | 0.260 |
Why?
|
| Language Disorders | 1 | 2007 | 21 | 0.260 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 2010 | 89 | 0.260 |
Why?
|
| Animals | 25 | 2025 | 33743 | 0.250 |
Why?
|
| Genetic Diseases, X-Linked | 3 | 2024 | 81 | 0.250 |
Why?
|
| Speech Disorders | 1 | 2007 | 46 | 0.250 |
Why?
|
| SOXD Transcription Factors | 2 | 2019 | 4 | 0.250 |
Why?
|
| Weight Gain | 1 | 2009 | 384 | 0.250 |
Why?
|
| Receptors, Cell Surface | 1 | 2008 | 420 | 0.240 |
Why?
|
| Channelopathies | 1 | 2026 | 12 | 0.240 |
Why?
|
| Cleft Lip | 1 | 2009 | 195 | 0.240 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2026 | 34 | 0.240 |
Why?
|
| Forkhead Transcription Factors | 2 | 2016 | 370 | 0.240 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2026 | 38 | 0.240 |
Why?
|
| SMARCB1 Protein | 1 | 2026 | 42 | 0.240 |
Why?
|
| Genomic Imprinting | 4 | 2016 | 121 | 0.230 |
Why?
|
| Cell Cycle Proteins | 4 | 2022 | 708 | 0.230 |
Why?
|
| Micrognathism | 1 | 2026 | 65 | 0.230 |
Why?
|
| Leukoencephalopathies | 2 | 2018 | 63 | 0.230 |
Why?
|
| Gain of Function Mutation | 1 | 2026 | 115 | 0.230 |
Why?
|
| Chromosome Mapping | 8 | 2016 | 1045 | 0.230 |
Why?
|
| Genotype | 12 | 2026 | 2590 | 0.230 |
Why?
|
| Chromosome Banding | 8 | 2014 | 135 | 0.220 |
Why?
|
| Neck | 1 | 2026 | 140 | 0.220 |
Why?
|
| Oligonucleotides | 1 | 2025 | 94 | 0.220 |
Why?
|
| Inheritance Patterns | 4 | 2021 | 127 | 0.220 |
Why?
|
| Point Mutation | 4 | 2019 | 332 | 0.220 |
Why?
|
| Natriuretic Agents | 1 | 2024 | 28 | 0.220 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2025 | 69 | 0.220 |
Why?
|
| Heterozygote | 6 | 2025 | 735 | 0.220 |
Why?
|
| Child Development | 2 | 2024 | 266 | 0.220 |
Why?
|
| Molecular Sequence Data | 14 | 2016 | 3461 | 0.220 |
Why?
|
| HEK293 Cells | 3 | 2026 | 799 | 0.220 |
Why?
|
| Abortion, Habitual | 1 | 2004 | 15 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 18 | 4 | 2011 | 59 | 0.210 |
Why?
|
| Zebrafish | 4 | 2020 | 416 | 0.210 |
Why?
|
| Radiography | 5 | 2016 | 741 | 0.210 |
Why?
|
| Paraganglioma | 1 | 2024 | 21 | 0.210 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2020 | 949 | 0.210 |
Why?
|
| Fractures, Bone | 2 | 2017 | 212 | 0.210 |
Why?
|
| Genomics | 7 | 2024 | 1621 | 0.210 |
Why?
|
| Mitochondrial Diseases | 1 | 2026 | 158 | 0.210 |
Why?
|
| Polydactyly | 1 | 2004 | 18 | 0.210 |
Why?
|
| Mediator Complex | 1 | 2024 | 62 | 0.210 |
Why?
|
| Anophthalmos | 1 | 2004 | 23 | 0.200 |
Why?
|
| Pseudohypoparathyroidism | 1 | 2023 | 5 | 0.200 |
Why?
|
| Agenesis of Corpus Callosum | 2 | 2024 | 49 | 0.200 |
Why?
|
| Cell Transdifferentiation | 1 | 2024 | 57 | 0.200 |
Why?
|
| Fasting | 1 | 2005 | 303 | 0.200 |
Why?
|
| Neurons | 3 | 2024 | 1971 | 0.200 |
Why?
|
| Genomic Instability | 3 | 2017 | 245 | 0.200 |
Why?
|
| Polymerase Chain Reaction | 4 | 2020 | 1445 | 0.200 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 288 | 0.200 |
Why?
|
| Drosophila melanogaster | 5 | 2025 | 787 | 0.190 |
Why?
|
| Lissencephaly | 1 | 2023 | 10 | 0.190 |
Why?
|
| Chromosomes, Human, Y | 1 | 2003 | 52 | 0.190 |
Why?
|
| Ferrets | 1 | 2023 | 13 | 0.190 |
Why?
|
| Turner Syndrome | 1 | 2003 | 44 | 0.190 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2024 | 156 | 0.190 |
Why?
|
| DNA Mutational Analysis | 8 | 2014 | 775 | 0.190 |
Why?
|
| Microtubule-Associated Proteins | 4 | 2018 | 248 | 0.180 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2022 | 23 | 0.180 |
Why?
|
| Facies | 5 | 2024 | 157 | 0.180 |
Why?
|
| Racemases and Epimerases | 1 | 2022 | 12 | 0.180 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2022 | 48 | 0.180 |
Why?
|
| Esophageal Atresia | 1 | 2022 | 52 | 0.180 |
Why?
|
| NADP | 1 | 2022 | 57 | 0.180 |
Why?
|
| NAD | 1 | 2022 | 52 | 0.180 |
Why?
|
| Activities of Daily Living | 1 | 2024 | 386 | 0.180 |
Why?
|
| Vulnerable Populations | 1 | 2024 | 151 | 0.180 |
Why?
|
| RNA, Long Noncoding | 1 | 2024 | 218 | 0.180 |
Why?
|
| DNA Methylation | 5 | 2025 | 1076 | 0.180 |
Why?
|
| Cytogenetic Analysis | 4 | 2012 | 78 | 0.170 |
Why?
|
| Cerebral Cortex | 2 | 2020 | 445 | 0.170 |
Why?
|
| Gastroenteritis | 1 | 2023 | 307 | 0.170 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2021 | 22 | 0.170 |
Why?
|
| Cardiovascular Abnormalities | 2 | 2014 | 51 | 0.170 |
Why?
|
| Sequence Analysis, RNA | 1 | 2024 | 407 | 0.170 |
Why?
|
| Lysosomes | 2 | 2022 | 267 | 0.170 |
Why?
|
| Obesity, Morbid | 1 | 2023 | 231 | 0.170 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2024 | 585 | 0.170 |
Why?
|
| Amniotic Band Syndrome | 1 | 2001 | 25 | 0.170 |
Why?
|
| Megalencephaly | 2 | 2018 | 59 | 0.170 |
Why?
|
| Movement Disorders | 1 | 2023 | 218 | 0.160 |
Why?
|
| Ultrasonography, Prenatal | 4 | 2016 | 986 | 0.160 |
Why?
|
| Drosophila Proteins | 2 | 2024 | 716 | 0.160 |
Why?
|
| Amino Acid Sequence | 6 | 2020 | 2392 | 0.160 |
Why?
|
| Exocrine Pancreatic Insufficiency | 2 | 2018 | 40 | 0.160 |
Why?
|
| Deafness | 2 | 2005 | 77 | 0.160 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2000 | 61 | 0.160 |
Why?
|
| Genetic Variation | 5 | 2021 | 1556 | 0.160 |
Why?
|
| Metabolic Diseases | 1 | 2022 | 143 | 0.160 |
Why?
|
| Sudden Infant Death | 1 | 2020 | 36 | 0.160 |
Why?
|
| Transcription Factors, General | 1 | 2020 | 6 | 0.160 |
Why?
|
| Hypothyroidism | 1 | 2020 | 71 | 0.160 |
Why?
|
| Cognition | 2 | 2010 | 825 | 0.160 |
Why?
|
| 14-3-3 Proteins | 3 | 2023 | 56 | 0.150 |
Why?
|
| Muscle Hypotonia | 4 | 2024 | 194 | 0.150 |
Why?
|
| INDEL Mutation | 1 | 2020 | 93 | 0.150 |
Why?
|
| Lymphangiectasis, Intestinal | 1 | 2019 | 1 | 0.150 |
Why?
|
| Body Weight | 1 | 2024 | 985 | 0.150 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2020 | 82 | 0.150 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2020 | 240 | 0.150 |
Why?
|
| Organogenesis | 1 | 2020 | 75 | 0.150 |
Why?
|
| Spine | 4 | 2011 | 151 | 0.150 |
Why?
|
| Microfibrils | 1 | 2019 | 1 | 0.150 |
Why?
|
| Lymphedema | 1 | 2019 | 18 | 0.150 |
Why?
|
| DNA Replication | 3 | 2017 | 355 | 0.150 |
Why?
|
| Mice | 11 | 2023 | 18209 | 0.150 |
Why?
|
| F-Box Proteins | 1 | 2019 | 33 | 0.150 |
Why?
|
| Aicardi Syndrome | 1 | 2019 | 17 | 0.150 |
Why?
|
| Epilepsy, Generalized | 1 | 2020 | 63 | 0.150 |
Why?
|
| Losartan | 1 | 2019 | 36 | 0.150 |
Why?
|
| Uridine Diphosphate Galactose | 1 | 2019 | 6 | 0.150 |
Why?
|
| Fibrillin-1 | 1 | 2019 | 59 | 0.150 |
Why?
|
| Young Adult | 11 | 2024 | 10042 | 0.150 |
Why?
|
| Organ Size | 1 | 2020 | 407 | 0.150 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2019 | 43 | 0.150 |
Why?
|
| Models, Biological | 1 | 2024 | 1371 | 0.150 |
Why?
|
| Mutagenesis, Insertional | 2 | 2010 | 150 | 0.150 |
Why?
|
| Growth | 1 | 2019 | 93 | 0.140 |
Why?
|
| Receptors, Notch | 1 | 2020 | 197 | 0.140 |
Why?
|
| Homologous Recombination | 3 | 2015 | 97 | 0.140 |
Why?
|
| Chromosomal Instability | 1 | 2019 | 59 | 0.140 |
Why?
|
| Rett Syndrome | 1 | 2021 | 229 | 0.140 |
Why?
|
| Phosphoglycerate Kinase | 1 | 2018 | 5 | 0.140 |
Why?
|
| Gene Dosage | 4 | 2013 | 434 | 0.140 |
Why?
|
| Lipomatosis | 1 | 2018 | 15 | 0.140 |
Why?
|
| Dwarfism | 1 | 2019 | 101 | 0.140 |
Why?
|
| Biomarkers | 5 | 2021 | 3371 | 0.140 |
Why?
|
| Congenital Disorders of Glycosylation | 1 | 2019 | 50 | 0.140 |
Why?
|
| Sleep Wake Disorders | 1 | 2021 | 202 | 0.140 |
Why?
|
| Malformations of Cortical Development | 1 | 2018 | 60 | 0.140 |
Why?
|
| Pediatric Obesity | 1 | 2023 | 419 | 0.140 |
Why?
|
| Testis | 1 | 2020 | 389 | 0.140 |
Why?
|
| Gametogenesis | 2 | 2017 | 26 | 0.140 |
Why?
|
| Zinc Fingers | 3 | 2025 | 116 | 0.140 |
Why?
|
| Bone Marrow Diseases | 1 | 2018 | 45 | 0.140 |
Why?
|
| Optic Atrophy, Autosomal Dominant | 1 | 2018 | 10 | 0.140 |
Why?
|
| Scoliosis | 2 | 2017 | 147 | 0.140 |
Why?
|
| Hypertrichosis | 1 | 2017 | 4 | 0.130 |
Why?
|
| Failure to Thrive | 2 | 2016 | 86 | 0.130 |
Why?
|
| Penetrance | 2 | 2016 | 107 | 0.130 |
Why?
|
| Quality of Life | 2 | 2026 | 2078 | 0.130 |
Why?
|
| Antiporters | 1 | 2017 | 35 | 0.130 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2020 | 889 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 22 | 2 | 2012 | 97 | 0.130 |
Why?
|
| Exercise Tolerance | 1 | 2018 | 91 | 0.130 |
Why?
|
| Alu Elements | 2 | 2015 | 66 | 0.130 |
Why?
|
| Mitochondrial Dynamics | 1 | 2018 | 56 | 0.130 |
Why?
|
| Fibronectins | 1 | 2017 | 99 | 0.130 |
Why?
|
| Cohort Studies | 8 | 2018 | 5049 | 0.130 |
Why?
|
| Larynx | 1 | 2018 | 73 | 0.130 |
Why?
|
| Antigens, Nuclear | 1 | 2017 | 52 | 0.130 |
Why?
|
| Tooth Abnormalities | 1 | 2017 | 13 | 0.130 |
Why?
|
| Nerve Net | 1 | 2020 | 253 | 0.130 |
Why?
|
| Levodopa | 1 | 2017 | 92 | 0.130 |
Why?
|
| Axons | 1 | 2020 | 381 | 0.130 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2018 | 3753 | 0.130 |
Why?
|
| Hepatoblastoma | 1 | 2019 | 204 | 0.130 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2018 | 125 | 0.130 |
Why?
|
| Cell Cycle | 1 | 2019 | 592 | 0.120 |
Why?
|
| Cerebellar Ataxia | 1 | 2017 | 61 | 0.120 |
Why?
|
| Fetal Diseases | 2 | 2014 | 440 | 0.120 |
Why?
|
| NF-kappa B | 1 | 2019 | 440 | 0.120 |
Why?
|
| Pancytopenia | 1 | 2016 | 40 | 0.120 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2016 | 37 | 0.120 |
Why?
|
| Chromosome Inversion | 1 | 2016 | 70 | 0.120 |
Why?
|
| Calcium Channels | 1 | 2017 | 143 | 0.120 |
Why?
|
| Wolf-Hirschhorn Syndrome | 1 | 2016 | 8 | 0.120 |
Why?
|
| Cell Movement | 1 | 2020 | 875 | 0.120 |
Why?
|
| Foot Deformities, Congenital | 2 | 2010 | 16 | 0.120 |
Why?
|
| Fanconi Anemia | 2 | 2011 | 48 | 0.120 |
Why?
|
| Folic Acid Deficiency | 2 | 2007 | 45 | 0.120 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2018 | 428 | 0.120 |
Why?
|
| Chorionic Villi Sampling | 2 | 2016 | 44 | 0.120 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 322 | 0.120 |
Why?
|
| Injections, Subcutaneous | 3 | 2021 | 136 | 0.120 |
Why?
|
| Signal Transduction | 5 | 2023 | 4661 | 0.120 |
Why?
|
| Amniocentesis | 2 | 2016 | 77 | 0.120 |
Why?
|
| Bone Remodeling | 1 | 2016 | 56 | 0.120 |
Why?
|
| MEF2 Transcription Factors | 1 | 2016 | 34 | 0.120 |
Why?
|
| Vitamin B Complex | 2 | 2019 | 36 | 0.120 |
Why?
|
| Peroxisomes | 1 | 2016 | 42 | 0.120 |
Why?
|
| Rhabdomyolysis | 1 | 2016 | 35 | 0.120 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 1999 | 261 | 0.110 |
Why?
|
| Segmental Duplications, Genomic | 2 | 2015 | 81 | 0.110 |
Why?
|
| Blood Vessels | 1 | 2016 | 91 | 0.110 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2017 | 150 | 0.110 |
Why?
|
| RNA, Messenger | 2 | 2020 | 2544 | 0.110 |
Why?
|
| DNA Damage | 1 | 2019 | 509 | 0.110 |
Why?
|
| Cell Proliferation | 2 | 2020 | 2459 | 0.110 |
Why?
|
| Contractile Proteins | 2 | 2006 | 15 | 0.110 |
Why?
|
| Dopa Decarboxylase | 1 | 2015 | 7 | 0.110 |
Why?
|
| Bone Density | 2 | 2020 | 366 | 0.110 |
Why?
|
| Pregnancy | 9 | 2023 | 7476 | 0.110 |
Why?
|
| Pulmonary Alveoli | 1 | 2016 | 139 | 0.110 |
Why?
|
| Myosins | 1 | 2015 | 41 | 0.110 |
Why?
|
| Muscle Weakness | 1 | 2016 | 88 | 0.110 |
Why?
|
| Aminoglycosides | 1 | 1995 | 44 | 0.110 |
Why?
|
| Coloboma | 2 | 2005 | 40 | 0.110 |
Why?
|
| Adiponectin | 2 | 2006 | 123 | 0.110 |
Why?
|
| RNA, Ribosomal | 1 | 1995 | 48 | 0.110 |
Why?
|
| Aromatic-L-Amino-Acid Decarboxylases | 1 | 2015 | 21 | 0.110 |
Why?
|
| Osteoporosis | 1 | 2016 | 133 | 0.110 |
Why?
|
| Arthrogryposis | 1 | 2015 | 37 | 0.110 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2016 | 83 | 0.110 |
Why?
|
| Genome-Wide Association Study | 4 | 2017 | 1829 | 0.110 |
Why?
|
| Homeodomain Proteins | 2 | 2017 | 555 | 0.110 |
Why?
|
| Treatment Outcome | 8 | 2026 | 12862 | 0.110 |
Why?
|
| Receptors, Lipoprotein | 1 | 2014 | 10 | 0.110 |
Why?
|
| Membrane Proteins | 5 | 2023 | 1590 | 0.110 |
Why?
|
| Infant, Premature, Diseases | 1 | 2016 | 254 | 0.100 |
Why?
|
| Family | 3 | 2019 | 587 | 0.100 |
Why?
|
| Neurodegenerative Diseases | 1 | 2017 | 279 | 0.100 |
Why?
|
| Pulmonary Veins | 1 | 2016 | 167 | 0.100 |
Why?
|
| Fingers | 1 | 2014 | 62 | 0.100 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 2014 | 31 | 0.100 |
Why?
|
| Fetal Movement | 1 | 1993 | 11 | 0.100 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2015 | 115 | 0.100 |
Why?
|
| Trans-Activators | 2 | 2009 | 695 | 0.100 |
Why?
|
| Aorta, Thoracic | 1 | 2018 | 526 | 0.100 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2017 | 499 | 0.100 |
Why?
|
| Muscle Contraction | 1 | 2014 | 145 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2022 | 484 | 0.100 |
Why?
|
| Isochromosomes | 2 | 2011 | 17 | 0.100 |
Why?
|
| Gene-Environment Interaction | 1 | 2014 | 127 | 0.100 |
Why?
|
| Mental Disorders | 3 | 2010 | 907 | 0.100 |
Why?
|
| Environment | 1 | 2014 | 149 | 0.100 |
Why?
|
| Tetraspanins | 1 | 2013 | 30 | 0.100 |
Why?
|
| Prenatal Diagnosis | 2 | 2016 | 612 | 0.100 |
Why?
|
| Microfilament Proteins | 2 | 2006 | 269 | 0.100 |
Why?
|
| Aging, Premature | 1 | 2013 | 31 | 0.100 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 2 | 2011 | 12 | 0.100 |
Why?
|
| beta Catenin | 1 | 2014 | 197 | 0.100 |
Why?
|
| Collagen Type II | 1 | 2013 | 23 | 0.100 |
Why?
|
| Germ Cells | 1 | 2014 | 201 | 0.100 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2012 | 3 | 0.100 |
Why?
|
| Dysostoses | 1 | 2012 | 2 | 0.100 |
Why?
|
| Genotyping Techniques | 1 | 2013 | 110 | 0.100 |
Why?
|
| Waardenburg Syndrome | 1 | 2012 | 10 | 0.100 |
Why?
|
| Anus, Imperforate | 2 | 2024 | 19 | 0.090 |
Why?
|
| Hand | 2 | 2013 | 93 | 0.090 |
Why?
|
| Hypertriglyceridemia | 1 | 2014 | 117 | 0.090 |
Why?
|
| Colitis | 1 | 2014 | 165 | 0.090 |
Why?
|
| Urinary Bladder | 1 | 2014 | 219 | 0.090 |
Why?
|
| Adenosine Deaminase | 1 | 2012 | 89 | 0.090 |
Why?
|
| RNA, Double-Stranded | 1 | 2012 | 56 | 0.090 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2012 | 37 | 0.090 |
Why?
|
| Short Bowel Syndrome | 1 | 2012 | 61 | 0.090 |
Why?
|
| Enteritis | 1 | 2012 | 52 | 0.090 |
Why?
|
| Electroencephalography | 3 | 2025 | 861 | 0.090 |
Why?
|
| Bayes Theorem | 1 | 2013 | 307 | 0.090 |
Why?
|
| Germ-Line Mutation | 1 | 2014 | 368 | 0.090 |
Why?
|
| Interferon Type I | 1 | 2012 | 119 | 0.090 |
Why?
|
| Vesicular Acetylcholine Transport Proteins | 1 | 2011 | 5 | 0.090 |
Why?
|
| Psychological Tests | 3 | 2010 | 86 | 0.090 |
Why?
|
| Actins | 1 | 2014 | 321 | 0.090 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2016 | 482 | 0.090 |
Why?
|
| Computational Biology | 1 | 2017 | 861 | 0.090 |
Why?
|
| Cells, Cultured | 4 | 2019 | 2884 | 0.090 |
Why?
|
| Nerve Growth Factors | 1 | 2011 | 65 | 0.090 |
Why?
|
| Eosinophilia | 1 | 2012 | 111 | 0.090 |
Why?
|
| Microsatellite Repeats | 3 | 2007 | 204 | 0.080 |
Why?
|
| T-Box Domain Proteins | 1 | 2012 | 122 | 0.080 |
Why?
|
| Colon | 1 | 2014 | 366 | 0.080 |
Why?
|
| Metabolomics | 1 | 2015 | 499 | 0.080 |
Why?
|
| Disease Progression | 2 | 2016 | 2195 | 0.080 |
Why?
|
| Collagen Type XI | 1 | 2010 | 4 | 0.080 |
Why?
|
| Nervous System Malformations | 1 | 2012 | 135 | 0.080 |
Why?
|
| DNA Repair | 2 | 2011 | 569 | 0.080 |
Why?
|
| Lipotropic Agents | 1 | 2010 | 5 | 0.080 |
Why?
|
| Syringomyelia | 1 | 2010 | 17 | 0.080 |
Why?
|
| Lod Score | 3 | 2006 | 126 | 0.080 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2010 | 83 | 0.080 |
Why?
|
| Family Health | 3 | 2012 | 240 | 0.080 |
Why?
|
| Animals, Genetically Modified | 2 | 2024 | 290 | 0.080 |
Why?
|
| Placebos | 1 | 2010 | 223 | 0.080 |
Why?
|
| Amino Acid Substitution | 3 | 2020 | 404 | 0.080 |
Why?
|
| Chromosomes, Human | 2 | 2007 | 118 | 0.080 |
Why?
|
| Chromosome Breakpoints | 3 | 2017 | 81 | 0.080 |
Why?
|
| DNA Primers | 2 | 2008 | 599 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2011 | 67 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2024 | 1607 | 0.080 |
Why?
|
| Receptors, Nicotinic | 1 | 2010 | 113 | 0.080 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2009 | 30 | 0.080 |
Why?
|
| Drug Combinations | 1 | 2010 | 267 | 0.070 |
Why?
|
| Clone Cells | 1 | 2009 | 152 | 0.070 |
Why?
|
| Gastritis | 1 | 2012 | 374 | 0.070 |
Why?
|
| Adenosine Triphosphate | 2 | 2022 | 265 | 0.070 |
Why?
|
| Foot | 1 | 2009 | 60 | 0.070 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2009 | 91 | 0.070 |
Why?
|
| Food Hypersensitivity | 1 | 2012 | 187 | 0.070 |
Why?
|
| Neural Pathways | 1 | 2010 | 269 | 0.070 |
Why?
|
| Ectromelia | 1 | 2008 | 3 | 0.070 |
Why?
|
| Anthropometry | 1 | 2009 | 187 | 0.070 |
Why?
|
| Motor Skills | 2 | 2024 | 72 | 0.070 |
Why?
|
| Genitalia | 1 | 2008 | 39 | 0.070 |
Why?
|
| Tetralogy of Fallot | 1 | 2010 | 170 | 0.070 |
Why?
|
| TRPV Cation Channels | 1 | 2009 | 42 | 0.070 |
Why?
|
| Eyelids | 1 | 2009 | 106 | 0.070 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2008 | 35 | 0.070 |
Why?
|
| Bone Marrow Cells | 1 | 2009 | 243 | 0.070 |
Why?
|
| Neutropenia | 1 | 2009 | 209 | 0.070 |
Why?
|
| Dietary Supplements | 1 | 2011 | 447 | 0.070 |
Why?
|
| Gene Expression | 3 | 2020 | 1481 | 0.070 |
Why?
|
| Genes, Recessive | 1 | 2008 | 193 | 0.070 |
Why?
|
| Hirsutism | 1 | 2007 | 22 | 0.070 |
Why?
|
| Basal Ganglia Diseases | 1 | 2007 | 22 | 0.070 |
Why?
|
| Dyskinesias | 1 | 2007 | 21 | 0.070 |
Why?
|
| Drosophila | 2 | 2024 | 739 | 0.060 |
Why?
|
| DNA Helicases | 2 | 2005 | 239 | 0.060 |
Why?
|
| Dynamins | 2 | 2018 | 51 | 0.060 |
Why?
|
| Diagnosis, Differential | 3 | 2018 | 1874 | 0.060 |
Why?
|
| B-Lymphocytes | 1 | 2009 | 509 | 0.060 |
Why?
|
| Algorithms | 1 | 2013 | 1674 | 0.060 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2009 | 284 | 0.060 |
Why?
|
| Cardiovascular Diseases | 2 | 2012 | 2111 | 0.060 |
Why?
|
| Facial Asymmetry | 1 | 2005 | 18 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2023 | 6432 | 0.060 |
Why?
|
| Genetic Counseling | 2 | 2017 | 236 | 0.060 |
Why?
|
| Corpus Callosum | 2 | 2019 | 104 | 0.060 |
Why?
|
| Cognition Disorders | 1 | 2009 | 555 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2024 | 617 | 0.060 |
Why?
|
| DNA, Complementary | 2 | 2022 | 421 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2014 | 5184 | 0.060 |
Why?
|
| alpha-Thalassemia | 1 | 2005 | 10 | 0.060 |
Why?
|
| Choanal Atresia | 1 | 2005 | 18 | 0.060 |
Why?
|
| Rubinstein-Taybi Syndrome | 1 | 2005 | 16 | 0.050 |
Why?
|
| Leucovorin | 1 | 2005 | 53 | 0.050 |
Why?
|
| Thumb | 1 | 2005 | 23 | 0.050 |
Why?
|
| Quantitative Trait Loci | 1 | 2006 | 317 | 0.050 |
Why?
|
| Radius | 1 | 2005 | 37 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2024 | 1486 | 0.050 |
Why?
|
| Face | 1 | 2026 | 192 | 0.050 |
Why?
|
| Obesity | 2 | 2006 | 2416 | 0.050 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2024 | 26 | 0.050 |
Why?
|
| Iran | 1 | 2004 | 93 | 0.050 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 2 | 2018 | 91 | 0.050 |
Why?
|
| Blepharophimosis | 1 | 2024 | 25 | 0.050 |
Why?
|
| Cartilage | 2 | 2017 | 52 | 0.050 |
Why?
|
| Personality Assessment | 1 | 2004 | 113 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2026 | 723 | 0.050 |
Why?
|
| DNA, Mitochondrial | 2 | 2017 | 232 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2009 | 1362 | 0.050 |
Why?
|
| Joints | 1 | 2004 | 25 | 0.050 |
Why?
|
| Syntaxin 16 | 1 | 2023 | 4 | 0.050 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2023 | 12 | 0.050 |
Why?
|
| Chromogranins | 1 | 2023 | 30 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2024 | 73 | 0.050 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2010 | 788 | 0.050 |
Why?
|
| Blepharoptosis | 1 | 2024 | 67 | 0.050 |
Why?
|
| Hyperphagia | 1 | 2023 | 42 | 0.050 |
Why?
|
| Energy Intake | 1 | 2006 | 502 | 0.050 |
Why?
|
| Monosomy | 1 | 2003 | 24 | 0.050 |
Why?
|
| Medically Underserved Area | 1 | 2024 | 86 | 0.050 |
Why?
|
| Risk Factors | 2 | 2016 | 11020 | 0.050 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2004 | 127 | 0.050 |
Why?
|
| Preimplantation Diagnosis | 1 | 2003 | 29 | 0.050 |
Why?
|
| Constipation | 1 | 2024 | 131 | 0.050 |
Why?
|
| Time Factors | 2 | 2021 | 6168 | 0.050 |
Why?
|
| Loss of Function Mutation | 1 | 2024 | 177 | 0.050 |
Why?
|
| Thrombocytopenia | 1 | 2005 | 222 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2023 | 3818 | 0.050 |
Why?
|
| Cell Line | 2 | 2020 | 2550 | 0.050 |
Why?
|
| Social Behavior | 1 | 2004 | 214 | 0.050 |
Why?
|
| Phosphatidylinositols | 1 | 2022 | 30 | 0.050 |
Why?
|
| Aneuploidy | 2 | 2014 | 138 | 0.050 |
Why?
|
| Dosage Compensation, Genetic | 2 | 2000 | 54 | 0.050 |
Why?
|
| Gait | 1 | 2023 | 141 | 0.050 |
Why?
|
| Eye Abnormalities | 2 | 2012 | 104 | 0.050 |
Why?
|
| Cholesterol | 1 | 2005 | 538 | 0.050 |
Why?
|
| Cilia | 1 | 2023 | 72 | 0.050 |
Why?
|
| Eye Movements | 1 | 2022 | 68 | 0.050 |
Why?
|
| Machine Learning | 1 | 2026 | 381 | 0.050 |
Why?
|
| PAX5 Transcription Factor | 1 | 2022 | 16 | 0.040 |
Why?
|
| Transposases | 1 | 2022 | 44 | 0.040 |
Why?
|
| Recurrence | 2 | 2017 | 1484 | 0.040 |
Why?
|
| Histidine | 1 | 2022 | 69 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2024 | 2900 | 0.040 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 2 | 2013 | 52 | 0.040 |
Why?
|
| Atrophy | 1 | 2022 | 247 | 0.040 |
Why?
|
| Bone Development | 1 | 2021 | 58 | 0.040 |
Why?
|
| Age of Onset | 2 | 2013 | 591 | 0.040 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2022 | 97 | 0.040 |
Why?
|
| Age Factors | 2 | 2006 | 2818 | 0.040 |
Why?
|
| Hereditary Sensory and Motor Neuropathy | 1 | 2001 | 38 | 0.040 |
Why?
|
| Checklist | 1 | 2022 | 97 | 0.040 |
Why?
|
| Ataxia | 1 | 2022 | 160 | 0.040 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2021 | 66 | 0.040 |
Why?
|
| Standard of Care | 1 | 2022 | 131 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2023 | 269 | 0.040 |
Why?
|
| Feedback | 1 | 2021 | 143 | 0.040 |
Why?
|
| Collagen Type X | 1 | 2020 | 2 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2021 | 304 | 0.040 |
Why?
|
| Amish | 1 | 2020 | 11 | 0.040 |
Why?
|
| Injection Site Reaction | 1 | 2020 | 8 | 0.040 |
Why?
|
| Anal Canal | 2 | 2011 | 88 | 0.040 |
Why?
|
| Pancreatic Diseases | 1 | 2020 | 41 | 0.040 |
Why?
|
| Fibroma | 1 | 2000 | 29 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 8 | 1 | 2020 | 12 | 0.040 |
Why?
|
| DNA Probes | 1 | 2000 | 117 | 0.040 |
Why?
|
| Gonads | 1 | 2000 | 32 | 0.040 |
Why?
|
| Y Chromosome | 1 | 2000 | 47 | 0.040 |
Why?
|
| Exercise | 1 | 2006 | 892 | 0.040 |
Why?
|
| Absorptiometry, Photon | 1 | 2020 | 194 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2005 | 803 | 0.040 |
Why?
|
| Nervous System Diseases | 1 | 2024 | 394 | 0.040 |
Why?
|
| ADAMTS Proteins | 1 | 2019 | 10 | 0.040 |
Why?
|
| Procollagen N-Endopeptidase | 1 | 2019 | 10 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 1999 | 48 | 0.040 |
Why?
|
| Nose | 1 | 2020 | 115 | 0.040 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2014 | 248 | 0.040 |
Why?
|
| Fatal Outcome | 2 | 2011 | 349 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2020 | 17662 | 0.040 |
Why?
|
| Neuromuscular Junction | 1 | 2020 | 87 | 0.040 |
Why?
|
| Comorbidity | 1 | 2004 | 1589 | 0.040 |
Why?
|
| Diet | 1 | 2006 | 1114 | 0.040 |
Why?
|
| Growth Charts | 1 | 2019 | 16 | 0.040 |
Why?
|
| Trachea | 2 | 2011 | 207 | 0.040 |
Why?
|
| Esophagus | 2 | 2011 | 233 | 0.040 |
Why?
|
| Gastrointestinal Agents | 1 | 2019 | 62 | 0.040 |
Why?
|
| Cricetulus | 1 | 2019 | 89 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2019 | 73 | 0.040 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 141 | 0.040 |
Why?
|
| Mitomycin | 1 | 1999 | 36 | 0.040 |
Why?
|
| CHO Cells | 1 | 2019 | 151 | 0.040 |
Why?
|
| Twins, Monozygotic | 1 | 2019 | 124 | 0.040 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2020 | 156 | 0.040 |
Why?
|
| Genetic Markers | 3 | 2006 | 587 | 0.040 |
Why?
|
| Cyclic GMP | 1 | 2019 | 90 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2020 | 250 | 0.040 |
Why?
|
| Ribonucleoprotein, U5 Small Nuclear | 1 | 2018 | 4 | 0.040 |
Why?
|
| Peptide Elongation Factors | 1 | 2018 | 12 | 0.040 |
Why?
|
| Ergometry | 1 | 2018 | 4 | 0.040 |
Why?
|
| Adipokines | 1 | 2019 | 119 | 0.040 |
Why?
|
| DNA | 3 | 2012 | 1397 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2019 | 165 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2018 | 136 | 0.030 |
Why?
|
| Homeostasis | 1 | 2022 | 711 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 2012 | 716 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 231 | 0.030 |
Why?
|
| Collagen | 1 | 2019 | 273 | 0.030 |
Why?
|
| Progeria | 1 | 2017 | 17 | 0.030 |
Why?
|
| Cutis Laxa | 1 | 2017 | 10 | 0.030 |
Why?
|
| Infant Care | 1 | 2017 | 45 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2018 | 146 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2017 | 45 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 348 | 0.030 |
Why?
|
| Prevalence | 1 | 2004 | 2693 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 708 | 0.030 |
Why?
|
| Facial Bones | 2 | 1997 | 31 | 0.030 |
Why?
|
| Models, Genetic | 2 | 2014 | 749 | 0.030 |
Why?
|
| Muscular Diseases | 1 | 2018 | 118 | 0.030 |
Why?
|
| Exercise Test | 1 | 2018 | 239 | 0.030 |
Why?
|
| Calcium Channels, N-Type | 1 | 2017 | 47 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2017 | 129 | 0.030 |
Why?
|
| GTP-Binding Protein beta Subunits | 1 | 2017 | 31 | 0.030 |
Why?
|
| Long-Term Potentiation | 1 | 2017 | 103 | 0.030 |
Why?
|
| Transcriptome | 1 | 2024 | 1098 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2017 | 116 | 0.030 |
Why?
|
| Histones | 1 | 2020 | 541 | 0.030 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2017 | 82 | 0.030 |
Why?
|
| Larva | 1 | 2017 | 241 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 121 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2017 | 137 | 0.030 |
Why?
|
| Tetrahydrofolates | 2 | 2007 | 15 | 0.030 |
Why?
|
| Models, Animal | 1 | 2018 | 449 | 0.030 |
Why?
|
| Base Composition | 2 | 2013 | 66 | 0.030 |
Why?
|
| Blood Component Transfusion | 1 | 2016 | 57 | 0.030 |
Why?
|
| Metalloendopeptidases | 1 | 2017 | 101 | 0.030 |
Why?
|
| Karyotype | 1 | 2016 | 30 | 0.030 |
Why?
|
| Chromatin | 1 | 2000 | 499 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 451 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 4663 | 0.030 |
Why?
|
| Texas | 2 | 2017 | 3663 | 0.030 |
Why?
|
| Neoplasms | 1 | 2011 | 2993 | 0.030 |
Why?
|
| Adenosine Triphosphatases | 1 | 2017 | 189 | 0.030 |
Why?
|
| Genes, Lethal | 1 | 2016 | 71 | 0.030 |
Why?
|
| Pandemics | 1 | 2023 | 1115 | 0.030 |
Why?
|
| Reference Values | 2 | 2007 | 673 | 0.030 |
Why?
|
| Arabs | 1 | 2016 | 29 | 0.030 |
Why?
|
| Cadherins | 1 | 2017 | 182 | 0.030 |
Why?
|
| Caregivers | 1 | 2022 | 597 | 0.030 |
Why?
|
| Golgi Apparatus | 1 | 2016 | 92 | 0.030 |
Why?
|
| Intrinsically Disordered Proteins | 1 | 2016 | 63 | 0.030 |
Why?
|
| Nucleic Acid Heteroduplexes | 1 | 1995 | 17 | 0.030 |
Why?
|
| Dihydroxyphenylalanine | 1 | 2015 | 9 | 0.030 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 1995 | 65 | 0.030 |
Why?
|
| Biopsy | 1 | 2019 | 1229 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 2016 | 156 | 0.030 |
Why?
|
| Whole Genome Sequencing | 1 | 2017 | 361 | 0.030 |
Why?
|
| Fetal Growth Retardation | 1 | 2017 | 253 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1995 | 84 | 0.030 |
Why?
|
| Filamins | 2 | 2006 | 26 | 0.030 |
Why?
|
| Embryonic Development | 1 | 2017 | 200 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2016 | 128 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2016 | 623 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2018 | 407 | 0.030 |
Why?
|
| Protein Domains | 1 | 2016 | 252 | 0.030 |
Why?
|
| Anxiety | 1 | 2022 | 1010 | 0.030 |
Why?
|
| Tyrosine | 1 | 2015 | 142 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2017 | 645 | 0.030 |
Why?
|
| Gene Editing | 1 | 2017 | 237 | 0.030 |
Why?
|
| X Chromosome Inactivation | 1 | 2014 | 59 | 0.030 |
Why?
|
| Kidney | 2 | 2011 | 1280 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2017 | 317 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2005 | 1457 | 0.030 |
Why?
|
| Fertilization in Vitro | 2 | 2007 | 153 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2017 | 957 | 0.030 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 77 | 0.030 |
Why?
|
| Neuroimaging | 1 | 2017 | 384 | 0.030 |
Why?
|
| Disease Management | 1 | 2017 | 557 | 0.030 |
Why?
|
| Ophthalmoplegia, Chronic Progressive External | 1 | 1993 | 8 | 0.030 |
Why?
|
| Computer Systems | 1 | 1993 | 35 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 2014 | 114 | 0.030 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2013 | 37 | 0.020 |
Why?
|
| Anemia, Sideroblastic | 1 | 1993 | 15 | 0.020 |
Why?
|
| Smith-Magenis Syndrome | 1 | 2014 | 107 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2013 | 54 | 0.020 |
Why?
|
| Brachydactyly | 1 | 2013 | 10 | 0.020 |
Why?
|
| Incidence | 1 | 2001 | 3336 | 0.020 |
Why?
|
| Nucleotide Motifs | 1 | 2013 | 51 | 0.020 |
Why?
|
| Pregnancy Trimester, Second | 1 | 1993 | 162 | 0.020 |
Why?
|
| Toes | 1 | 2013 | 27 | 0.020 |
Why?
|
| Osteopetrosis | 1 | 2013 | 15 | 0.020 |
Why?
|
| Cell Division | 1 | 2014 | 717 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2008 | 2080 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 2320 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2017 | 788 | 0.020 |
Why?
|
| Hypopigmentation | 1 | 2012 | 13 | 0.020 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2012 | 12 | 0.020 |
Why?
|
| Hirschsprung Disease | 1 | 2012 | 39 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2017 | 1441 | 0.020 |
Why?
|
| Calcium | 1 | 2017 | 1008 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 334 | 0.020 |
Why?
|
| Exosomes | 1 | 2013 | 60 | 0.020 |
Why?
|
| Risk | 1 | 2014 | 723 | 0.020 |
Why?
|
| Abnormal Karyotype | 1 | 2012 | 8 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2014 | 322 | 0.020 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2013 | 52 | 0.020 |
Why?
|
| Gene Library | 1 | 2013 | 212 | 0.020 |
Why?
|
| Skull | 1 | 1993 | 148 | 0.020 |
Why?
|
| Protein Interaction Maps | 1 | 2012 | 93 | 0.020 |
Why?
|
| Critical Care | 1 | 2017 | 686 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 981 | 0.020 |
Why?
|
| Length of Stay | 1 | 2017 | 1413 | 0.020 |
Why?
|
| Receptors, Glycine | 1 | 2011 | 16 | 0.020 |
Why?
|
| Middle Aged | 3 | 2024 | 28454 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2013 | 359 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2012 | 550 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2016 | 871 | 0.020 |
Why?
|
| Amniotic Fluid | 1 | 2012 | 146 | 0.020 |
Why?
|
| Anisotropy | 1 | 2010 | 117 | 0.020 |
Why?
|
| LIM Domain Proteins | 1 | 2010 | 64 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2012 | 732 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2012 | 263 | 0.020 |
Why?
|
| Child Language | 1 | 2010 | 19 | 0.020 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2013 | 182 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2010 | 241 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2010 | 177 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 421 | 0.020 |
Why?
|
| Introns | 1 | 2010 | 278 | 0.020 |
Why?
|
| Aged | 2 | 2024 | 20917 | 0.020 |
Why?
|
| GATA4 Transcription Factor | 1 | 2009 | 35 | 0.020 |
Why?
|
| Inverted Repeat Sequences | 1 | 2009 | 12 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2012 | 1061 | 0.020 |
Why?
|
| Templates, Genetic | 1 | 2009 | 52 | 0.020 |
Why?
|
| Blotting, Southern | 2 | 2003 | 203 | 0.020 |
Why?
|
| DNA Breaks | 1 | 2009 | 25 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 1369 | 0.020 |
Why?
|
| Data Collection | 1 | 2011 | 370 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 927 | 0.020 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2010 | 255 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2012 | 531 | 0.020 |
Why?
|
| Polymorphism, Genetic | 2 | 2003 | 776 | 0.020 |
Why?
|
| Hearing Loss | 1 | 2010 | 203 | 0.020 |
Why?
|
| Skin Pigmentation | 1 | 2008 | 29 | 0.020 |
Why?
|
| Ribonuclease H | 1 | 2007 | 4 | 0.020 |
Why?
|
| Chilblains | 1 | 2007 | 3 | 0.020 |
Why?
|
| Psychomotor Disorders | 1 | 2007 | 30 | 0.020 |
Why?
|
| Psychometrics | 1 | 2011 | 678 | 0.020 |
Why?
|
| Lymphocytosis | 1 | 2007 | 15 | 0.020 |
Why?
|
| Exodeoxyribonucleases | 1 | 2007 | 52 | 0.020 |
Why?
|
| Allelic Imbalance | 1 | 2007 | 11 | 0.020 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2006 | 28 | 0.020 |
Why?
|
| Diet Surveys | 1 | 2006 | 98 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2006 | 87 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 2299 | 0.010 |
Why?
|
| Calcinosis | 1 | 2007 | 180 | 0.010 |
Why?
|
| Schizophrenia | 1 | 2008 | 324 | 0.010 |
Why?
|
| RNA Splice Sites | 1 | 2005 | 92 | 0.010 |
Why?
|
| Health Surveys | 1 | 2006 | 261 | 0.010 |
Why?
|
| Reduced Folate Carrier Protein | 1 | 2005 | 18 | 0.010 |
Why?
|
| Hemoglobin H | 1 | 2005 | 1 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2007 | 447 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2006 | 582 | 0.010 |
Why?
|
| Acetyltransferases | 1 | 2005 | 74 | 0.010 |
Why?
|
| Hemoglobins, Abnormal | 1 | 2005 | 12 | 0.010 |
Why?
|
| CREB-Binding Protein | 1 | 2005 | 54 | 0.010 |
Why?
|
| Genetic Heterogeneity | 1 | 2005 | 132 | 0.010 |
Why?
|
| Codon, Terminator | 1 | 2004 | 24 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2005 | 403 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2005 | 257 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2004 | 410 | 0.010 |
Why?
|
| Physical Chromosome Mapping | 1 | 2003 | 55 | 0.010 |
Why?
|
| Loss of Heterozygosity | 1 | 2003 | 123 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2005 | 448 | 0.010 |
Why?
|
| Protein Transport | 1 | 2004 | 366 | 0.010 |
Why?
|
| United States | 1 | 2018 | 12030 | 0.010 |
Why?
|
| Sex Factors | 1 | 2006 | 1348 | 0.010 |
Why?
|
| Early Growth Response Protein 2 | 1 | 2001 | 9 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2001 | 242 | 0.010 |
Why?
|
| Gonadoblastoma | 1 | 2000 | 1 | 0.010 |
Why?
|
| CpG Islands | 1 | 2001 | 336 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2006 | 1704 | 0.010 |
Why?
|
| Diseases in Twins | 1 | 1999 | 86 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2000 | 422 | 0.010 |
Why?
|
| Haplotypes | 1 | 2000 | 517 | 0.010 |
Why?
|
| Cerebral Palsy | 1 | 1999 | 86 | 0.010 |
Why?
|
| Blotting, Western | 1 | 1999 | 1013 | 0.010 |
Why?
|
| Sucking Behavior | 1 | 1997 | 21 | 0.010 |
Why?
|
| Feeding and Eating Disorders | 1 | 1997 | 74 | 0.010 |
Why?
|
| Lung Diseases | 1 | 1997 | 396 | 0.010 |
Why?
|